Keywords: repligen, lilly, cooperate, corp, reports, eli, develop

Repligen and Lilly to cooperate

Article | 08 June 1992

- Repligen Corp reports that it will cooperate with Eli Lilly to develop, test and market antibody-based inflammation therapeutics. Lilly will ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Lilly

Go to company listing